bioAffinity Technologies, Inc.
Ticker(s):
BIAF and BIAFW
Country:
Sector & Industry:
Business Overview
bioAffinity Technologies, Inc. engages in developing non-invasive diagnostics to detect early-stage lung cancer and other diseases of the lung. It offers CyPath lung, a diagnostic test, for early detection of lung cancer. The company was incorporated in 2014 and is based in San Antonio, Texas.
Contact & Other Information
Number of Employees:
75
Website:
22211 West Interstate 10
Suite 1206
San Antonio
,
TX
,
78257
United States
210 698 5334
No content was found.